Mermaid Medical has introduced its latest soft tissue biopsy solutions, the M∙Biopsy® Semi-Automatic and Fully Automatic Biopsy Needles.
Introducing the M∙Biopsy® Semi-Automatic and Fully Automatic Biopsy Instruments
Mermaid Medical has introduced its latest soft tissue biopsy solutions, the M∙Biopsy® Semi-Automatic and Fully Automatic Biopsy Needles.
A Clinical Necessity
Soft tissue biopsies play a crucial role in modern medicine by helping doctors diagnose a wide range of conditions, including cancer and autoimmune diseases. They provide essential information about the nature of tissues, enabling clinicians to make informed decisions about treatment and patient management.
The M∙Biopsy® Semi-Automatic Biopsy Needle
The semi-automatic version of the M∙Biopsy® Biopsy Needle offers a high degree of flexibility that is invaluable in clinical settings. With adjustable throw lengths of 10mm and 20mm, it can be tailored to meet individual procedural requirements effectively. This adaptability is particularly beneficial for clinicians conducting biopsies guided by advanced imaging techniques like CT scans, where precision is of utmost importance. Additionally, its lightweight design and color-coded gauge identification further enhance its usability in clinical practice.
The M∙Biopsy® Fully Automatic Biopsy Needle
The fully automatic M∙Biopsy® Biopsy Needle has been designed with a strong focus on user-friendliness and precision. It features an ergonomic design and a two-stage loading button, providing a comfortable grip, and reducing the force needed to operate the device. This design minimizes needle movement during imaging, a critical factor in obtaining high-quality biopsy samples. With throw length options of 11mm or 22mm, it accommodates a wide spectrum of clinical requirements.
Prioritizing Precision and Patient Comfort
In the scope of soft tissue biopsies, precision and patient comfort are utmost. Mermaid Medical's M∙Biopsy® Semi-Automatic and Fully Automatic Biopsy Needles prioritize these factors, offering clinicians the tools they need to provide accurate diagnoses while ensuring the well-being of their patients.
For inquiries or further information about Mermaid Medical's soft tissue biopsy solutions, please contact us: mermaidmedical.com/contact-us/
Mermaid Medical Group announces new exclusive distribution deal on the COBRA-OS® device for REBOA procedures from Front Line Medical Technologies Inc.
Mermaid Medical is proud to announce the appointment of Marcus Kildegaard Nielsen as the new global Sales Director, effective September 1st, 2024. Over the past six years, Marcus has made significant contributions in sales and marketing, bringing the right skills, ambitions, and mindset to ensure we keep driving the business forward.
Mermaid Medical proudly welcomes Daniel Nilsson Lennartz as the new Business Development Director, effective September 1st, 2024. As one of the co-founders, Daniel brings invaluable insights and expertise that will continue to drive the company’s growth and long-term success.